ABL90 FLEX PLUS Analyzer
Device Devices
PDI 05700693930923
General payments
$1,639
Research payments
$4,793,148
Through program year 2025, $1,639 in general payments and $4,793,148 in research payments were reported against ABL90 FLEX PLUS Analyzer (Devices).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $91,013 | 10 |
| 2024 | General | $454 | 1 |
| 2024 | Research | $1,458,678 | 91 |
| 2023 | General | $1,169 | 4 |
| 2023 | Research | $3,243,457 | 26 |
| 2022 | General | $16 | 1 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
6 general · 127 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.